| 產(chǎn)品名稱 | Cabozantinib S-malate - XL 184 |
| 產(chǎn)品貨號(hào) | Axon 1819 CAS [1140909-48-3] MF C28H24FN3O5.C4H6O5MW 635.59 Purity: 99% Soluble in DMSO Description A orally available and potent inhibitor of multiple receptor tyrosine kinases (RTK), specifically MET and VEGFR2. It also inhibits KIT, FLT3, Tie-2, RET and AXL References Certificates Categories Extra info M Yakes et al.?Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth. Mol. Cancer Ther. 2011, 10(12), 2298-2308.? Certificate of Analysis Material Safety Data Sheet Angiogenesis Cell Signaling & Oncology Axl c-MET FLT3 VEGFR c-KIT RTK class IV and X; EC 2.7.10.1 Inhibitor of multiple receptor tyrosine kinases, specifically MET and VEGFR2 Chemical name N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (S)-2-hydroxysuccinate Parent CAS No. [849217-68-1] Order Size Unit Price Stock 10 mg €85.00 In Stock |
| 產(chǎn)品價(jià)格 | 現(xiàn)貨詢價(jià)，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
Cabozantinib S-malate - XL 184Axon 1819 CAS [1140909-48-3] MF C28H24FN3O5.C4H6O5
Description
A orally available and potent inhibitor of multiple receptor tyrosine kinases (RTK), specifically MET and VEGFR2. It also inhibits KIT, FLT3, Tie-2, RET and AXL
Inhibitor of multiple receptor tyrosine kinases, specifically MET and VEGFR2
Chemical nameN-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (S)-2-hydroxysuccinate Parent CAS No.[849217-68-1] |
| 產(chǎn)品資料 |
